For private equity and venture capital
Clinical and health plan expertise for healthcare investors
Financial, legal, and technical diligence are standard. Clinical diligence and health plan market expertise usually are not, and investors rarely know where to find them. Dueringer Advisors gives you a clinician and health plan operator from thesis through exit.
The gap
What the financial model cannot tell you
Payer-facing companies live or die on whether health plans buy, renew, and trust them. That depends on clinical, regulatory, and operational realities that rarely show up in a data room.
Do the outcome claims hold up?
Stars, HEDIS, and care management results are easy to claim and hard to prove.
Will health plans actually buy?
Plan buying cycles, vendor oversight, and delegation rules often run longer and stricter than the model assumes.
Where is the regulatory exposure?
CMS, state, and accreditation requirements can turn a growth plan into a compliance problem.
Is the clinical program real?
Care models, UM workflows, and AI tools need clinical review, not only a product demo.
How we support investors
From investment thesis to exit
01
Thesis and sourcing
- Market and thesis validation across MA, Medicaid, D-SNP, and Commercial
- Regulatory tailwinds and headwinds that affect the thesis
- Target screening for health plan market fit
02
Diligence
- Clinical program and care model review
- Stars, HEDIS, and outcome claim validation
- Regulatory, compliance, and accreditation risk
- Clinical review of AI and technology products
- Health plan buyer and sales cycle assessment
- Clinical and operational leadership assessment
03
Value creation
- Go-to-market strategy for the health plan market
- Expansion into new lines of business
- Accreditation and compliance readiness
- Care model and clinical program strengthening
- Operational excellence, leadership development, and restructuring
04
Ongoing advisory and exit
- Fractional clinical advisor to portfolio companies
- Clinical perspective for investment committees
- Exit readiness: a clinical and quality story buyers can verify
Who we work with
Investors and acquirers
- Private equity firms
- Venture capital firms
- Growth equity investors
- Strategic acquirers
Companies we evaluate
Anything that sells to or serves health plans
Health tech and AI companies
Care management and navigation vendors
Stars, HEDIS, and quality vendors
Member engagement companies
Utilization management and clinical review services
Health plans and plan services companies
Why investors work with us
The plan-side view, before you commit capital
Clinician and operator
Led by a Registered Nurse and Board-Certified Case Manager with more than 20 years in managed care.
We know how plans buy
We have run the plan-side work your target is selling into, so we test the thesis the way a plan buyer would.
Independent
We do not sell for, refer for, or broker introductions for the companies we evaluate. We check for conflicts before every engagement. Our only job is an honest answer.
Confidential
Deal work stays private. We never name clients or targets.
How to engage
Built around deal timelines
Expert calls
Targeted hours to pressure-test a thesis, a claim, or a management answer.
Diligence project
A scoped clinical and operational diligence review, sized to your deal timeline, with a written findings report.
Portfolio advisory
Ongoing fractional clinical and health plan advisory for one or more portfolio companies.
Investor questions
Can you work within our deal timeline?
Yes. We scope each diligence review to the timeline and the questions that matter most to your investment decision.
Will you introduce portfolio companies to health plans?
No. We advise on go-to-market strategy and how plans buy. The company runs its own sales. That independence is what makes our diligence credible.
Do you work under NDA?
Yes. We sign NDAs as standard practice and never name clients, targets, or portfolio companies.
How do you handle conflicts of interest?
Before we take on any diligence or advisory work, we check for conflicts. We disclose any financial interest or advisory relationship with the target. If a conflict cannot be managed, we decline the engagement. We do not take compensation from a company we are evaluating for you.
Do you only review Medicare Advantage companies?
No. We cover Medicare Advantage, Medicaid, Dual Eligible Special Needs Plans, Chronic Condition Special Needs Plans, and Commercial.